Highlights of 2025 in low- and intermediate-risk prostate cancer
About this episode
In this episode, UROONCO PCa associate editor Prof. Claudia Kesch (DE) interviews Dr. Jochen Walz (FR) about the key highlights of 2025 in low- to intermediate-risk prostate cancer.
They discuss advances in imaging diagnostics, artificial intelligence and biomarkers, active surveillance, surgical techniques and radiotherapy, as well as what is anticipated in 2026.
Here are the links to the articles and interviews on the trials which were mentioned in this podcast:
For more updates on prostate cancer, please visit our educational platform UROONCO PCa.
For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Get every episode summarized
Each time EAU Podcasts publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from EAU Podcasts
EAUN edition - No place to go: Homelessness & Incontinence
EAU Podcasts
EAU Section of Genitourinary Reconstructive Surgeons: Management of short bulbar...
EAU Podcasts
History Office: Ongoing discoveries from the life of Joaquín Albarrán (1860-1912...
EAU Podcasts
PEACE 2 results: Evaluating pelvic RT for very high-risk PCa
EAU Podcasts